Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses how prostate cancer requires an integrated multidisciplinary approach. Related ReadingEnhancing prostate cancer care through…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
Anna Ferrari, MD, Professor and Co-Director GU Research at NYU Langone Medical Center, discusses the diagnosis of prostate cancer and what a man needs to know. The three…
NEW YORK (Reuters Health) – A low-dose regimen of peginterferon, without ribavirin, produces a sustained virologic response in up to 40% of patients with chronic hepatitis C and…
NEW YORK (Reuters Health) – Pain associated with diabetic neuropathy is improved to a similar degree with daily amitriptyline or duloxetine, according to the results of a cross-over…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
NEW YORK (Reuters Health) – Ribavirin added to pegylated interferon more than doubles the sustained viral response rate in children with chronic hepatitis C, a multicenter team reports…
NEW YORK (Reuters Health) – For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a…
NEW YORK (Reuters Health) – Compared to conventional white light bronchoscopy, autofluorescence bronchoscopy is more sensitive in detecting lung cancer and preneoplastic lesions, according to a meta-analysis conducted…
NEW YORK (Reuters Health) – HCV genotype 4, previously limited to Egypt and parts of Africa, has now spread to southern Europe and other parts of world, an…
